Current Report Filing (8-k)
04 January 2023 - 10:04PM
Edgar (US Regulatory)
false 0001801777 0001801777 2022-12-29 2022-12-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 3, 2023 (December 29, 2022)
APPLIED MOLECULAR TRANSPORT INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
001-39306 |
|
81-4481426 |
| (State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
450 East Jamie Court
South San Francisco, CA 94080
(Address of principal executive offices, including zip code)
(650) 392-0420
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
| Title of each class |
|
Trading
Symbol |
|
Name of exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
AMTI |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. |
(b) On December 29, 2022, Randall Mrsny, Ph.D., informed the Board of Directors (the “Board”) of Applied Molecular Transport Inc. that he was resigning from the Board effective on such date.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
| APPLIED MOLECULAR TRANSPORT INC. |
|
|
| By: |
|
/s/ Earl Douglas |
|
|
Earl Douglas |
|
|
Executive Vice President, General Counsel and Secretary |
Date: January 3, 2022
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Apr 2023 to Apr 2024
